ProstaLund
5.7
SEK
0 %
Less than 1K followers
PLUN
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
0%
-31.33%
-24.4%
-39.62%
-65.33%
-88.42%
-97.09%
-90.32%
-98.44%
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Read moreMarket cap
20.66M SEK
Turnover
575.95 SEK
Revenue
13.73M
EBIT %
-163.8 %
P/E
-
Dividend yield-%
-
Financial calendar
16.5
2025
Interim report Q1'25
27.5
2025
General meeting '25
21.8
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective
ProstaLund AB - Year-end report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools